Solid clinical trial data and a payer contract are no longer the benchmarks for commercial success in today's dynamic market. Payers' influence continues to grow. Combine that with the potential changes included in health reform proposals and the increasing demand for comparative effectiveness data, and it's clear that the formula for effective product commercialization has become substantially more complex.
Join us on Tuesday, April 20 at 2:00PM (Eastern) as we launch our five-part webcast series, “Ensuring Patient Access to Products in the Evolving Healthcare Market.” In part one, Xcenda Vice President Matt Sarnes and Director Laura Happe will discuss how manufacturers are revamping their approach to managed care messaging to increase their products' market opportunity. Key points for their presentation include:
MODERATOR
Stacie Heller
Senior Director
Xcenda
SPEAKERS
Matt Sarnes, PharmD
Vice President
Xcenda
Laura Happe, PharmD, MPH
Director
Xcenda